| # | Ticker | Company | Price | Chg % | Mkt Cap | P/E | EPS Growth TTM | Div Yield | Sector | Return 1Y | Revenue Growth… | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | United Therapeutics Corporation | $563.70 | 3% | $23.93B | 20.2 | 7.9% | — | Healthcare | 94.1% | 5.9% | ||
| 2 | Jazz Pharmaceuticals plc | $247.72 | 1.5% | $15.54B | -42.4 | -98.5% | — | Healthcare | 130.2% | 9.2% | ||
| 3 | Alkermes plc | $55.22 | 0.1% | $9.2B | 38.6 | -56.9% | — | Healthcare | 88.9% | 3.2% | ||
| 4 | Liquidia Corporation | $81.23 | 2.6% | $7.22B | -101.5 | 108.9% | — | Healthcare | 552.4% | 1936.7% | ||
| 5 | Arcutis Biotherapeutics, Inc. | $27.67 | 6.1% | $3.46B | -212.8 | 96.7% | — | Healthcare | 106.6% | 95.3% | ||
| 6 | Zai Lab Limited | $19.35 | 1.4% | $2.14B | -12.1 | 87.9% | — | Healthcare | -45.5% | 8.4% | ||
| 7 | ADMA Biologics, Inc. | $9.21 | 0.5% | $2.13B | 15.4 | -20% | — | Healthcare | -48.5% | 11% | ||
| 8 | Mineralys Therapeutics, Inc. | $30.46 | 4.6% | $2.02B | -13.3 | 45% | — | Healthcare | 125.1% | — | ||
| 9 | Ardelyx, Inc. | $5.38 | 0.7% | $1.32B | -20.7 | -4.8% | — | Healthcare | 23.7% | 18.2% | ||
| 10 | Unicycive Therapeutics, Inc. | $5.43 | 1.3% | $1.3B | -3.3 | 45.1% | — | Healthcare | 15.8% | — | ||
| 11 | Phathom Pharmaceuticals, Inc. | $11.55 | 1.5% | $917M | -3.8 | 59.5% | — | Healthcare | 33.4% | 150.3% | ||
| 12 | Theravance Biopharma, Inc. | $16.98 | -0.1% | $875M | 8.2 | 286.8% | — | Healthcare | 50.1% | 68.2% | ||
| 13 | Tenax Therapeutics, Inc. | $13.29 | -8.7% | $601M | -9.9 | 43.1% | — | Healthcare | 131.1% | — | ||
| 14 | Akebia Therapeutics, Inc. | $1.36 | 4.6% | $365M | -65.4 | 63.3% | — | Healthcare | -62.5% | 25.7% | ||
| 15 | Amarin Corporation plc | $15.46 | -1.7% | $322M | -8.6 | 62.1% | — | Healthcare | -7.1% | 0.3% | ||
| 16 | Sol-Gel Technologies Ltd. | $78.44 | 5.8% | $220M | -35.7 | 70.2% | — | Healthcare | 976% | 282.9% | ||
| 17 | Jyong Biotech Ltd. Ordinary Shares | $2.19 | -0.5% | $166M | -34.2 | — | — | Healthcare | -72% | — | ||
| 18 | Milestone Pharmaceuticals Inc. | $1.29 | -2.3% | $111M | -1.7 | 13.9% | — | Healthcare | -40.6% | — | ||
| 19 | Pelthos Therapeutics Inc. | $24.60 | -1.1% | $81M | -1.1 | -228.1% | — | Healthcare | -5.2% | — | ||
| 20 | Verrica Pharmaceuticals Inc. | $6.07 | -1% | $65M | -3.6 | 87% | — | Healthcare | -26.9% | 417.6% | ||
| 21 | Daré Bioscience, Inc. | $2.05 | -1.4% | $30M | -1.7 | -477.4% | — | Healthcare | -14.6% | 4366.5% | ||
| 22 | Cuprina Holdings (Cayman) Limited Class A Ordinary Shares | $5.74 | 1.4% | $15M | -4.0 | — | — | Healthcare | -89.5% | — | ||
| 23 | Palatin Technologies, Inc. | $10.99 | -0.2% | $12M | -0.3 | -63.8% | — | Healthcare | 63.3% | 3581.2% | ||
| 24 | Citius Pharmaceuticals, Inc. | $0.58 | -4% | $7M | -0.2 | 56% | — | Healthcare | -72.3% | 3498.8% | ||
| 25 | Processa Pharmaceuticals, Inc. | $1.89 | -10% | $4M | -0.2 | 86.1% | — | Healthcare | 875.2% | — | ||
| 26 | NKGen Biotech, Inc. Common Stock | $0.06 | 0% | $3M | -0.0 | 69.6% | — | Healthcare | -80% | — | ||
| 27 | InMed Pharmaceuticals Inc. | $1.67 | 3.7% | $3M | -0.2 | -8939.1% | — | Healthcare | -38.8% | 13390.6% | ||
| 28 | CASI Pharmaceuticals, Inc. | $0.15 | 3.8% | $2M | -0.1 | -41.7% | 31.1% | Healthcare | -88.7% | 21.7% | ||
| 29 | OSR Holdings, Inc. | $0.31 | -3.4% | $1M | -0.1 | 9.5% | — | Healthcare | -76.4% | 355% | ||
| 30 | Avenue Therapeutics, Inc. | $0.33 | 8.2% | $1M | -0.4 | 88% | — | Healthcare | 3.5% | — | ||
| 31 | Lipella Pharmaceuticals Inc. | $0.07 | -10.1% | $327082 | -0.0 | 41.3% | — | Healthcare | -91.6% | -61.4% | ||
| 32 | Jaguar Health, Inc. | $2.56 | -8.9% | $170598 | -0.0 | 87.6% | — | Healthcare | -97.1% | 156% | ||
| 33 | Windtree Therapeutics, Inc. | $0.01 | -14.7% | $387 | -0.0 | 99.1% | 100% | Healthcare | -98.2% | — |